418 related articles for article (PubMed ID: 34105198)
1. COVID-19 associated brain/spinal cord lesions and leptomeningeal enhancement: A meta-analysis of the relationship to CSF SARS-CoV-2.
Lewis A; Jain R; Frontera J; Placantonakis DG; Galetta S; Balcer L; Melmed KR
J Neuroimaging; 2021 Sep; 31(5):826-848. PubMed ID: 34105198
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid in COVID-19: A systematic review of the literature.
Lewis A; Frontera J; Placantonakis DG; Lighter J; Galetta S; Balcer L; Melmed KR
J Neurol Sci; 2021 Feb; 421():117316. PubMed ID: 33561753
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal Fluid Features in Patients With Coronavirus Disease 2019 and Neurological Manifestations: Correlation with Brain Magnetic Resonance Imaging Findings in 58 Patients.
Lersy F; Benotmane I; Helms J; Collange O; Schenck M; Brisset JC; Chammas A; Willaume T; Lefebvre N; Solis M; Hansmann Y; Fabacher T; Caillard S; Mertes PM; Pottecher J; Schneider F; Meziani F; Fafi-Kremer S; Kremer S
J Infect Dis; 2021 Feb; 223(4):600-609. PubMed ID: 33249438
[TBL] [Abstract][Full Text] [Related]
4. What can cerebrospinal fluid testing and brain autopsies tell us about viral neuroinvasion of SARS-CoV-2.
Li YC; Zhang Y; Tan BH
J Med Virol; 2021 Jul; 93(7):4247-4257. PubMed ID: 33724490
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid findings in patients with seizure in the setting of COVID-19: A review of the literature.
Carroll E; Melmed KR; Frontera J; Placantonakis DG; Galetta S; Balcer L; Lewis A
Seizure; 2021 Jul; 89():99-106. PubMed ID: 34044299
[TBL] [Abstract][Full Text] [Related]
6. A Systematic Review on Neurological Aspects of COVID-19: Exploring the Relationship Between COVID-19-Related Olfactory Dysfunction and Neuroinvasion.
Purja S; Oh S; Kim E
Front Neurol; 2022; 13():887164. PubMed ID: 35911902
[TBL] [Abstract][Full Text] [Related]
7. CSF Biomarkers in Patients With COVID-19 and Neurologic Symptoms: A Case Series.
Edén A; Kanberg N; Gostner J; Fuchs D; Hagberg L; Andersson LM; Lindh M; Price RW; Zetterberg H; Gisslén M
Neurology; 2021 Jan; 96(2):e294-e300. PubMed ID: 33004602
[TBL] [Abstract][Full Text] [Related]
8. Evidence of central nervous system infection and neuroinvasive routes, as well as neurological involvement, in the lethality of SARS-CoV-2 infection.
Liu JM; Tan BH; Wu S; Gui Y; Suo JL; Li YC
J Med Virol; 2021 Mar; 93(3):1304-1313. PubMed ID: 33002209
[TBL] [Abstract][Full Text] [Related]
9. Clinical Implications of COVID-19 Presence in CSF: Systematic Review of Case Reports.
Elmakaty I; Ferih K; Karen O; Ouda A; Elsabagh A; Amarah A; Malki MI
Cells; 2022 Oct; 11(20):. PubMed ID: 36291083
[TBL] [Abstract][Full Text] [Related]
10. Neuroimaging manifestations in children with SARS-CoV-2 infection: a multinational, multicentre collaborative study.
Lindan CE; Mankad K; Ram D; Kociolek LK; Silvera VM; Boddaert N; Stivaros SM; Palasis S;
Lancet Child Adolesc Health; 2021 Mar; 5(3):167-177. PubMed ID: 33338439
[TBL] [Abstract][Full Text] [Related]
11. Anti-SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome: Studies in 8 stuporous and comatose patients.
Alexopoulos H; Magira E; Bitzogli K; Kafasi N; Vlachoyiannopoulos P; Tzioufas A; Kotanidou A; Dalakas MC
Neurol Neuroimmunol Neuroinflamm; 2020 Nov; 7(6):. PubMed ID: 32978291
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 and autoantibodies in the cerebrospinal fluid of COVID-19 patients: prospective multicentre cohort study.
Nersesjan V; Amiri M; Nilsson AC; Wamberg C; Jensen VVS; Petersen CB; Hejl AM; Lebech AM; Theut AM; Jørgensen CS; Blaabjerg M; Benros ME; Kondziella D
Brain Commun; 2023; 5(5):fcad274. PubMed ID: 37908236
[TBL] [Abstract][Full Text] [Related]
13. COVID-19-associated meningoencephalitis: A care report and literature review.
Lv P; Peng F; Zhang Y; Zhang L; Li N; Sun L; Wang Y; Hou P; Huang T; Wang X
Exp Ther Med; 2021 Apr; 21(4):362. PubMed ID: 33732335
[TBL] [Abstract][Full Text] [Related]
14. First report of manic-like symptoms in a COVID-19 patient with no previous history of a psychiatric disorder.
Lu S; Wei N; Jiang J; Wu L; Sheng J; Zhou J; Fang Q; Chen Y; Zheng S; Chen F; Liang T; Hu S
J Affect Disord; 2020 Dec; 277():337-340. PubMed ID: 32858315
[TBL] [Abstract][Full Text] [Related]
15. Computing the Effects of SARS-CoV-2 on Respiration Regulatory Mechanisms in COVID-19.
Baig AM
ACS Chem Neurosci; 2020 Aug; 11(16):2416-2421. PubMed ID: 32600045
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2: is there neuroinvasion?
McQuaid C; Brady M; Deane R
Fluids Barriers CNS; 2021 Jul; 18(1):32. PubMed ID: 34261487
[TBL] [Abstract][Full Text] [Related]
17. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.
Yachou Y; El Idrissi A; Belapasov V; Ait Benali S
Neurol Sci; 2020 Oct; 41(10):2657-2669. PubMed ID: 32725449
[TBL] [Abstract][Full Text] [Related]
18. A systematic review of neurological manifestations of SARS-CoV-2 infection: the devil is hidden in the details.
Romoli M; Jelcic I; Bernard-Valnet R; García Azorín D; Mancinelli L; Akhvlediani T; Monaco S; Taba P; Sellner J;
Eur J Neurol; 2020 Sep; 27(9):1712-1726. PubMed ID: 32503088
[TBL] [Abstract][Full Text] [Related]
19. Neurological symptoms in COVID-19: a cross-sectional monocentric study of hospitalized patients.
Ermis U; Rust MI; Bungenberg J; Costa A; Dreher M; Balfanz P; Marx G; Wiesmann M; Reetz K; Tauber SC; Schulz JB
Neurol Res Pract; 2021 Mar; 3(1):17. PubMed ID: 33712089
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of Patients with SARS-CoV-2 Positive Cerebrospinal Fluid: A Systematic Review.
Salman MA; Mallah SI; Khalid W; Ryan Moran L; Abousedu YAI; Jassim GA
Int J Gen Med; 2021; 14():10385-10395. PubMed ID: 35002295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
